Compass Pathways Plc (CMPS)
10.75
-0.87
(-7.49%)
USD |
NASDAQ |
Oct 16, 16:00
10.88
+0.13
(+1.21%)
After-Hours: 20:00
Compass Pathways Cash and Short Term Investments (Quarterly) : 433.72M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 433.72M |
| March 31, 2026 | 466.39M |
| December 31, 2025 | 149.99M |
| September 30, 2025 | 186.32M |
| June 30, 2025 | 222.26M |
| March 31, 2025 | 260.49M |
| December 31, 2024 | 165.47M |
| September 30, 2024 | 207.34M |
| June 30, 2024 | 229.02M |
| March 31, 2024 | 263.28M |
| December 31, 2023 | 220.64M |
| September 30, 2023 | 248.37M |
| June 30, 2023 | 148.48M |
| Date | Value |
|---|---|
| March 31, 2023 | 117.37M |
| December 31, 2022 | 143.38M |
| September 30, 2022 | 173.23M |
| June 30, 2022 | 207.28M |
| March 31, 2022 | 243.79M |
| December 31, 2021 | 273.35M |
| September 30, 2021 | 294.06M |
| June 30, 2021 | 316.36M |
| March 31, 2021 | 179.55M |
| December 31, 2020 | 190.36M |
| September 30, 2020 | 196.53M |
| June 30, 2020 | 67.63M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Silence Therapeutics Plc | 72.05M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 25.89M |
| Mereo BioPharma Group Plc | 30.12M |
| HemoGenyx Pharmaceuticals Plc | -- |